1 / 23

Subcutaneous Drug Delivery Market Analysis (2020-2027)

Read here the market research report on the u201cSubcutaneous Drug Delivery Market" published by CMI Team

kunalbhuta
Télécharger la présentation

Subcutaneous Drug Delivery Market Analysis (2020-2027)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. SUBCUTANEOUS DRUG DELIVERY MARKET ANALYSIS -(2020-2027) • Subcutaneous Drug Delivery Market, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Autoinjector (Spring Type, Motorized Type, and Wearable Type), Prefilled Pen (Disposable and Reusable), Vial (Syringe), and Pump and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

  3. The market comprises products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates, to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to drive the market growth.

  4. Market Dynamics • Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. Moreover, in 2019, YpsoMed developed YpsoMateSmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected with an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.

  5. Key features of the study: • This report provides in-depth analysis of the global subcutaneous drug delivery market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global subcutaneous drug delivery market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans

  6. Market Opportunities • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc., Novartis International AG, Insulet Corporation, West Pharmaceutical Services, Inc., and Gerresheimer AG • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics • The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

  7. Detailed Segmentation: • Global Subcutaneous Drug Delivery Market, By Usability: • Disposable • Reusable • Global Subcutaneous Drug Delivery Market, By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others

  8. Global Subcutaneous Drug Delivery Market, By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type • Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others

  9. Global Subcutaneous Drug Delivery Market, By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies

  10. Global Subcutaneous Drug Delivery Market, By Region: • North America • By Usability: • Disposable • Reusable • By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others

  11. By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • By Country: • U.S. • Canada • Latin America • By Usability: • Disposable • Reusable • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type • Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others

  12. Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others • By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type

  13. By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • Europe • By Usability: • Disposable • Reusable

  14. By Country: • Germany • U.K. • France • Italy • Spain • Russia • Rest of Europe • Asia Pacific • By Usability: • Disposable • Reusable • Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others • By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies

  15. Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others • By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type

  16. By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type • By Country: • China • India • Japan • Australia • South Korea • ASEAN • Rest of Asia Pacific • Middle East • By Usability: • Disposable • Reusable

  17. By Country/Region: • GCC • Israel • Rest of Middle East • Africa • By Usability: • Disposable • Reusable • Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others • By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies

  18. Prefilled Pen • Disposable • Reusable • Vial (Syringe) • Pump and Others • By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • By Country/Region: • South Africa • Central Africa • North Africa • By Disease Indication: • Auto-immune Disorders • Neurological Disorders • Oncology Disorders • Hormonal Disorders • Allergy & Infectious Disorders • Ophthalmic Disorders • Others • By Delivery Type: • Prefilled Syringe • Autoinjector • Spring Type • Motorized Type • Wearable Type

  19. Johnson & Johnson • Sanofi S.A. • Teva Pharmaceutical Industries Ltd. • Amgen, Inc. • F. Hoffmann-La Roche AG • Consort Medical plc • Eli Lilly and Company • Merck & Co., Inc. • Novartis International AG • Insulet Corporation • West Pharmaceutical Services, Inc. • Gerresheimer AG • “*” marked represents similar segmentation in other categories in the respective section. • Company Profiles • Becton, Dickinson and Company* • Company Overview • Material Portfolio • Financial Performance • Key Highlights • Market Strategies • Novo Nordisk A/S

  20. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933

  21. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  22. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  23. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related